Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · Real-Time Price · USD
104.48
+1.97 (1.92%)
At close: May 9, 2025, 4:00 PM
104.48
0.00 (0.00%)
After-hours: May 9, 2025, 4:05 PM EDT
Ligand Pharmaceuticals Employees
Ligand Pharmaceuticals had 68 employees as of December 31, 2024. The number of employees increased by 10 or 17.24% compared to the previous year.
Employees
68
Change (1Y)
10
Growth (1Y)
17.24%
Revenue / Employee
$2,668,941
Profits / Employee
-$1,950,324
Market Cap
2.01B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
LGND News
- 1 day ago - Ligand Pharmaceuticals Incorporated (LGND) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Ligand Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 8 days ago - Ligand to Participate in May Investor Conferences - GlobeNewsWire
- 15 days ago - Ligand to Report First Quarter 2025 Financial Results on May 8, 2025 - GlobeNewsWire
- 22 days ago - Ligand Subsidiary Pelthos Therapeutics to Combine with Channel Therapeutics - GlobeNewsWire
- 2 months ago - Ligand to Participate in March Investor Conferences - GlobeNewsWire
- 2 months ago - Ligand Pharmaceuticals Incorporated (LGND) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Ligand Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire